| Trifluridine/Tipiracil (TAS-102) With or Without Thalidomide for the Treatment of Metastatic Colorectal Cancer (NCT05266820) | Fujian Cancer Hospital | 2021-10-01 |
| Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer (NCT05035446) | Fujian Cancer Hospital | 2021-10-01 |
| PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma (NCT05007145) | Fujian Cancer Hospital | 2021-08-15 |
| Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma (NCT04955886) | Fujian Cancer Hospital | 2021-08-01 |
| Almonertinib as First-line Treatment in Patients With EGFR+ Positive Pulmonary Adenosquamous Carcinoma or Combined Adenocarcinoma and Squamous Cell Carcinoma (NCT04354961) | Fujian Cancer Hospital | 2021-05-07 |
| Using Mini Program for Self-management VS Conventional Pharmaceutical Care for Cancer Pain (NCT04844645) | Fujian Cancer Hospital | 2021-05-01 |
| Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC (NCT04745741) | Fujian Cancer Hospital | 2021-05-01 |
| Second-line Surufatinib Combined With Chemotherapy in Advanced CRC (NCT04734249) | Fujian Cancer Hospital | 2021-03-01 |
| Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy (NCT04613804) | Fujian Cancer Hospital | 2020-12-01 |
| Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain (NCT04533243) | Fujian Cancer Hospital | 2020-09-01 |
| Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC (NCT04421469) | Fujian Cancer Hospital | 2020-06-15 |
| To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC (NCT04387266) | Fujian Cancer Hospital | 2020-06-01 |
| Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration (NCT04243954) | Fujian Cancer Hospital | 2020-04-10 |
| Study of the Apatinib Combine With POF Versus POF in Gastric Cancer (NCT04121039) | Fujian Cancer Hospital | 2019-12-01 |
| Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC (NCT04220528) | Fujian Cancer Hospital | 2019-12-01 |
| POF Versus FOLFOX Plus IP Paclitaxel in AGC (NCT04155671) | Fujian Cancer Hospital | 2019-12-01 |
| Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma (NCT03788174) | Fujian Cancer Hospital | 2019-02-01 |
| Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma (NCT03708536) | Fujian Cancer Hospital | 2018-11-01 |
| Study of the Combination of Apatinib and POF (NCT03707639) | Fujian Cancer Hospital | 2018-11-01 |
| Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain (NCT03639415) | Fujian Cancer Hospital | 2018-10-30 |
| EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC (NCT03648697) | Fujian Cancer Hospital | 2018-10-10 |
| EGFR-TKIs Combine With Anlotinib as First-line Treatment for Patients With Advanced EGFR Mutation-positive NSCLC (NCT03720873) | Fujian Cancer Hospital | 2018-10-01 |
| PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain (NCT03375515) | Fujian Cancer Hospital | 2018-09-29 |
| Cognitive Dysfunction in Patients With Cancer Pain (NCT03641820) | Fujian Cancer Hospital | 2018-08-21 |
| Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal Cancer (NCT03518489) | Fujian Cancer Hospital | 2018-07-01 |
| Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel (NCT03566576) | Fujian Cancer Hospital | 2018-07-01 |
| Gefitinib and Berberine in the First-line Treatment of Lung Adenocarcinoma With EGFR Mutation (NCT03486496) | Fujian Cancer Hospital | 2018-06-05 |
| Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma (NCT03486509) | Fujian Cancer Hospital | 2018-04-01 |
| Effects of Anesthesia on Tumor Immunity and Insulin Resistance During Perioperative Period (NCT03872635) | Fujian Cancer Hospital | 2018-01-01 |
| Phase I Study of the Combination of Apatinib and POF (NCT03244774) | Fujian Cancer Hospital | 2018-01-01 |
| Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment (NCT03244904) | Fujian Cancer Hospital | 2017-11-01 |